These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17156707)

  • 1. Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1.
    Margari L; Presicci A; Ventura P; Maria Bacca S; Iliceto G; Medicamento N; Buttiglione M; Perniola T
    J Child Neurol; 2006 Dec; 21(12):1085-90. PubMed ID: 17156707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological findings in neurofibromatosis type 1.
    Yerdelen D; Koc F; Durdu M; Karakas M
    J Neurol Sci; 2011 Jul; 306(1-2):42-8. PubMed ID: 21501851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood.
    Ammendola A; Ciccone G; Ammendola E
    Pediatr Neurol; 2006 Apr; 34(4):276-80. PubMed ID: 16638501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative results of data of brain stem auditory evoked potentials and imaging during an evaluation of the course of Recklinghausen's neurofibromatosis].
    Loth D; Teyssou M; Avan P; Menguy C; Maitre S
    Ann Otolaryngol Chir Cervicofac; 1989; 106(4):239-44. PubMed ID: 2506788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1.
    Cutting LE; Koth CW; Burnette CP; Abrams MT; Kaufmann WE; Denckla MB
    J Child Neurol; 2000 Mar; 15(3):157-60. PubMed ID: 10757470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.
    Raininko R; Thelin L; Eeg-Olofsson O
    Neuropediatrics; 2001 Oct; 32(5):225-30. PubMed ID: 11748492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function.
    Goh WH; Khong PL; Leung CS; Wong VC
    J Child Neurol; 2004 Nov; 19(11):853-8. PubMed ID: 15658789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.
    Joy P; Roberts C; North K; de Silva M
    Dev Med Child Neurol; 1995 Oct; 37(10):906-14. PubMed ID: 7493724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1: magnetic resonance imaging findings.
    DiMario FJ; Ramsby G; Greenstein R; Langshur S; Dunham B
    J Child Neurol; 1993 Jan; 8(1):32-9. PubMed ID: 8445170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood multiple sclerosis (MS): multimodal evoked potentials (EP) and magnetic resonance imaging (MRI) comparative study.
    Scaioli V; Rumi V; Cimino C; Angelini L
    Neuropediatrics; 1991 Feb; 22(1):15-23. PubMed ID: 2038422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1 presenting with hand dystonia.
    Di Capua M; Lispi ML; Giannotti A; Longo D; Fariello G
    J Child Neurol; 2001 Aug; 16(8):606-8. PubMed ID: 11510936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
    Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of gadolinium-enhanced lesions in patients affected by neurofibromatosis type 1.
    Lucchetta M; Manara R; Perilongo G; Clementi M; Trevisson E
    Radiol Med; 2016 Mar; 121(3):214-7. PubMed ID: 26445946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?
    Rüegger AD; Coleman L; Hansford JR; McLean N; Dabscheck G
    Pediatr Neurol; 2018 Sep; 86():63-65. PubMed ID: 30174245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearing enhancing brain lesion in a child with neurofibromatosis type I.
    Morris PW; Glasier CM; Smirniotopoulos JG; Allison JW
    Pediatr Radiol; 1997 Mar; 27(3):260-1. PubMed ID: 9126587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of clinical, MRI and multimodality evoked potentials in neurologic Wilson disease.
    Das M; Misra UK; Kalita J
    Eur J Neurol; 2007 May; 14(5):498-504. PubMed ID: 17437607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of MRI abnormalities in children with neurofibromatosis.
    Duffner PK; Cohen ME; Seidel FG; Shucard DW
    Neurology; 1989 Mar; 39(3):373-8. PubMed ID: 2494565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.